Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference

      Share Article
      share to

      New Brunswick, N.J., August 26, 2021 -- Johnson & Johnson (NYSE: JNJ) will participate in the Cantor Virtual Global Healthcare Conference on Tuesday, September 28th. Mathai Mammen, Global Head, Research & Development Janssen Research Development and Scott White, Company Group Chairman NA Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately 48-hrs after the live webcast.

      ###

      Press Contacts
      Christina Chan
      (732) 524-6297

      Courtney Dugan
      (347) 452-1061

      Investor Contact
      Jen McIntyre
      (732) 524-3922

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.